Tonix Pharmaceuticals Holding Corp At Investor Summit (Virtual) Transcript
Good morning, everyone, and thank you for tuning in to Investor Summit's March event. Joining us right now today is Jessica Morris, Chief Operating Officer at Tonix Pharmaceuticals. Jessica, I'm going to let you go ahead and get started.
Great. Thank you very much, Gage, and thank you for having Tonix as a presenter at the Investor Summit conference today. I am sharing my screen. Hopefully, everyone can see that. This next slide is just our forward-looking statements disclosure. I will be making forward-looking statements, and we are a public company. So, I would direct you to our SEC filings, including our 10-K that was recently filed.
Tonix is a clinical stage biopharmaceutical company, and our mission is to improve population health by inventing and developing new therapies as well as new vaccines. And we do this through not only our broad in-house capabilities, but also strategic collaborations to address important unmet needs in very large markets
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
